103 related articles for article (PubMed ID: 29768767)
1. Benefit-risk management in the age of personalized healthcare.
Forstner M
Per Med; 2012 Jul; 9(5):507-514. PubMed ID: 29768767
[TBL] [Abstract][Full Text] [Related]
2. Personalized medicine: using effective partnering for managing the risk of legal liability.
Roth M
Per Med; 2007 Aug; 4(3):329-339. PubMed ID: 29788660
[TBL] [Abstract][Full Text] [Related]
3. Towards a framework for personalized healthcare: lessons learned from the field of rare diseases.
Tambuyzer E
Per Med; 2010 Sep; 7(5):569-586. PubMed ID: 29776250
[TBL] [Abstract][Full Text] [Related]
4. Will personalized medicine help in 'transforming' the business of healthcare?
Lester DS
Per Med; 2009 Sep; 6(5):555-565. PubMed ID: 29783307
[TBL] [Abstract][Full Text] [Related]
5. Role of Proteomics in the Development of Personalized Medicine.
Jain KK
Adv Protein Chem Struct Biol; 2016; 102():41-52. PubMed ID: 26827601
[TBL] [Abstract][Full Text] [Related]
6. Models of partnership between the pharmaceutical and diagnostics industries around companion diagnostics for cancer and beyond.
Ensinger C
Expert Opin Med Diagn; 2011 Mar; 5(2):91-4. PubMed ID: 23480583
[TBL] [Abstract][Full Text] [Related]
7. Human genome project: pharmacogenomics and drug development.
Ganguly NK; Bano R; Seth SD
Indian J Exp Biol; 2001 Oct; 39(10):955-61. PubMed ID: 11883519
[TBL] [Abstract][Full Text] [Related]
8. The re-emerging concept of personalized healthcare.
Xu LH; Zheng H; Sedmak DD; Sadée W
Per Med; 2008 Sep; 5(5):457-469. PubMed ID: 29783441
[TBL] [Abstract][Full Text] [Related]
9. Molecular profiling and companion diagnostics: where is personalized medicine in cancer heading?
Verma M
Per Med; 2014 Nov; 11(8):761-771. PubMed ID: 29764045
[TBL] [Abstract][Full Text] [Related]
10. Improving the power of diagnostics in the era of targeted therapy and personalized healthcare.
Walk EE
Curr Opin Drug Discov Devel; 2010 Mar; 13(2):226-34. PubMed ID: 20205056
[TBL] [Abstract][Full Text] [Related]
11. Delivering on the promise of personalized healthcare.
March R
Per Med; 2010 May; 7(3):327-337. PubMed ID: 29776220
[TBL] [Abstract][Full Text] [Related]
12. DxS Ltd.
Little S
Pharmacogenomics; 2003 Jan; 4(1):97-101. PubMed ID: 12517290
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenomics: current applications and future prospects towards personalized therapeutics.
Vaiopoulou A; Gazouli M; Karikas GA
J BUON; 2013; 18(3):570-8. PubMed ID: 24065466
[TBL] [Abstract][Full Text] [Related]
14. A perspective analysis: companion diagnostics: an evolving paradigm in 21st century healthcare.
Kaufmann M; Keppens M; Blair ED
Per Med; 2015 Aug; 12(4):389-402. PubMed ID: 29771658
[TBL] [Abstract][Full Text] [Related]
15. Challenges of implementing personalized (precision) medicine: a focus on diabetes.
Fodor A; Karnieli E
Per Med; 2016 Sep; 13(5):485-497. PubMed ID: 29767596
[TBL] [Abstract][Full Text] [Related]
16. Role of nanobiotechnology in developing personalized medicine for cancer.
Jain KK
Technol Cancer Res Treat; 2005 Dec; 4(6):645-50. PubMed ID: 16292884
[TBL] [Abstract][Full Text] [Related]
17. Safe and effective medicines for all: is personalized medicine the answer?
Cascorbi I
Expert Rev Clin Pharmacol; 2010 Sep; 3(5):627-37. PubMed ID: 22111745
[TBL] [Abstract][Full Text] [Related]
18. Enabling personalized medicine in Europe: a look at the European Commission's funding activities in the field of personalized medicine research.
Draghia-Akli R
Per Med; 2012 Mar; 9(2):151-155. PubMed ID: 29758818
[TBL] [Abstract][Full Text] [Related]
19. [Personalized medicine and individual healthcare : Medical and information technology aspects].
Niederlag W; Lemke HU; Rienhoff O
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Aug; 53(8):776-82. PubMed ID: 20700776
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
